4//SEC Filing
Sanchez Ramiro 4
Accession 0000950170-23-073591
CIK 0001805387other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 4:15 PM ET
Size
8.4 KB
Accession
0000950170-23-073591
Insider Transaction Report
Form 4
Sanchez Ramiro
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-26$3.50/sh+10,000$35,000→ 24,673 total - Sale
Common Stock
2023-12-26$42.47/sh−10,000$424,700→ 14,673 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-26−10,000→ 538,435 totalExercise: $3.50Exp: 2029-02-27→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 4, 2023 adopted by the Reporting Person.
- [F2]The option is fully vested and exercisable.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001830326
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 4:15 PM ET
- Size
- 8.4 KB